Has Jack Bert, MD received payments from drug or device companies?

Yes. Drug and device makers reported $147,633 in general payments to Jack Bert, MD across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jack Bert, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jack Bert, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jack Bert, MD

Orthopaedic Surgery · Woodbury, MNNPI 1457310542

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $109,832 of the $147,633 with a category attached, or 74.4%. 6 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 50.9% of the total. Reporting peaked in 2019 at $76,675 and has fallen 73.0% since, to $20,733 in 2024. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$147,633in general payments, 2019–2025

Across 83 payments — averaging $1778.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi-aventis U.S. LLC$75K
Pacira Therapeutics, Inc.$49K
Bioventus LLC$19K
Terumo BCT, Inc.$3K
Arthrex$1K
Averitas Pharma Inc.$64

What the payments were for

Consulting fees$26,38118%
Speaking & faculty fees$109,83274%
Travel & lodging$9,8667%
Food & beverage$1,5551%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi-aventis U.S. LLC	26	$75,181
Pacira Therapeutics, Inc.	39	$49,403
Bioventus LLC	14	$18,845
Terumo BCT, Inc.	1	$3,000
Arthrex	2	$1,140
Averitas Pharma Inc.	1	$64

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Zilretta$48,798
SYNVISC$45,437
SYNVISC-ONE$22,073
Durolane$9,773
NO PRODUCT DISCUSSED$7,384
Bone Marrow Aspirate Concentrate System$3,000
Bioness - Other$2,800
Stimrouter Implantable Kit$188

How this compares

$147,633 in reported general payments places this provider in the 90th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024

$14,013

Medicare patients

Services billed

549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	32	$900
Methylprednisolone	13	$94

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Woodbury

Daniel BerryRochester$21.5M
Mark PagnanoRochester$14.8M
Robert TrousdaleRochester$12.2M
John SperlingRochester$12.2M
Shawn O'DriscollRochester$10.5M
Bryan Den HartogStillwater$9M
Joseph NesslerSartell$8.6M
David LewallenRochester$8M
Rafael SierraRochester$4.9M
Mark DahlOak Park Heights$4M

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →